Pouch manufacturing 101: what every founder should know

Pouches come in three broad moisture profiles, each with different manufacturing processes, release characteristics, and consumer experiences.

Moist pouches contain 40–55% water content. They deliver actives rapidly (2–5 minutes onset), have a softer mouthfeel, and are the traditional format for Scandinavian-style products. Manufacturing requires moisture-controlled production and refrigerated or climate-controlled supply chain.

Semi-moist pouches contain 20–35% water. They're the dominant modern format (think Zyn, Rogue, VELO). Onset is 5–10 minutes, mouthfeel is firmer, and shelf stability is dramatically better than moist — room temperature, 12+ months. This is the format most new brands should default to.

Dry pouches contain under 15% water. Uncommon but useful for specific functional formulations where moisture would degrade the active, or where a slower, extended-release profile is desired.

Pouches deliver actives through oral mucosal absorption — the tissue lining the mouth and gums. This absorption pathway bypasses first-pass liver metabolism, meaning active doses are bioavailable at lower amounts than oral ingestion.

For caffeine, a 50mg pouch delivers effective stimulation comparable to a 100mg oral capsule. For nicotine, the ratio is even more pronounced. For functional actives (adaptogens, nootropics, vitamins), bioavailability varies by molecule — your formulation partner should have empirical data on each active.

Release curve is controllable through pouch moisture, active concentration gradient, and flavor masking systems. Fast-release pouches deliver 70%+ of active in the first 10 minutes. Sustained-release formulations dose more evenly across 30–45 minutes.

Pouch manufacturing is a 12-stage process at minimum: ingredient intake and QC, blend formulation, moisture conditioning, pouch filler material cutting, active dosing, pouch sealing, packaging into cans, can sealing, label application, secondary packaging, final QC and batch sampling, and warehouse release.

Every stage requires documentation for regulated products (dietary supplements, nicotine pouches, any product with health claims). A good manufacturer maintains full batch records with retention samples stored for 2+ years.

Minimum order quantities vary by product complexity. Platform formulations (pre-developed recipes the manufacturer owns) typically start at 50,000 cans. Custom formulations start at 100,000–250,000 cans. Novel active formulations may require 500,000+ to justify the R&D investment.

Per-can cost scales dramatically with volume. A 50,000-can run might cost $1.80–$2.50 per can all-in. A 500,000-can run might cost $0.90–$1.30. This delta is the single biggest determinant of whether your unit economics work.

For a first launch, plan for a 50,000–100,000 unit run at $2+ per can cost. Your retail price should be 4–6x that cost for sustainable margins across DTC, wholesale, and marketing spend.

Look for: GMP certification at minimum, FDA facility registration for U.S. supply, in-house R&D team (not outsourced), regulatory staff with specific category experience, MOQ flexibility, 4–8 week lead time capability, and transparent cost breakdowns.

Red flags: manufacturers that won't discuss MOQ until you share your business plan, long lead times (12+ weeks is industry-standard but not competitive), opaque ingredient sourcing, no regulatory support, or formulations that can't be documented to batch level.